Trial Profile
A 12-Week Randomized, Double-Blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms LOADET
- Sponsors Wyeth
- 08 Apr 2022 This trial has been completed (End Date: 06 Aug 2008), according to European Clinical Trials Database record.
- 16 Jun 2010 Results presented at 11th Annual Congress of the European League Against Rheumatism (EULAR) 2010
- 14 Aug 2009 Actual end date changed from Feb 2008 to Jun 2008 and actual number of patients (108) added as reported by ClinicalTrials.gov.